NCT04504604
- Conditions
- Adenocarcinoma, Cancer of Unknown Primary Site, Carcinoma, +10 more
- Locations
-
- TargetCancer Foundation Cambridge, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Rare Cancers. Study availability and eligibility vary by location and protocol.
NCT04504604
NCT05852522
NCT01505400